Craig Nelson, MD

Response Rates of Esketamine Nasal Spray Plus an Oral Antidepressant Among Patients Not Meeting Study Criteria for Early Response to Treatment

Objective: Esketamine nasal spray (ESK) plus a newly initiated antidepressant (AD) reduces depression symptoms in patients with treatment-resistant depression (TRD), in a subset meeting s...

Samuel Wilkinson , MD, PhD;

Craig Nelson , MD;

Giacomo Salvadore , MD;

Ibrahim Turkoz , PhD;

Ella Daly , MB, BCh, BAO;

Jaskaran Singh , MD;

David Williamson , PhD, MBA;

Abigail Nash , MD, PhD;

Xiwu Lin , PhD;

Yevgen Tymofyeyev , PhD;

11/22/2019

Economic Burden of Treatment Resistant Depression in Privately Insured US Patients With Behavioral Comorbidities

BACKGROUND: Incremental economic burden of treatment resistant depression (TRD) in patients with behavioral comorbidities is largely unknown.

Craig Nelson , MD;

Carmine Rossi , PhD;

Ella Daly , MB, BCh, BAO;

Maryia Zhdanava , MA;

Harsh Kuvadia ;

Patrick Lefebvre , MA;

Dominic Pilon , MA;

Kruti Joshi , MPH, MD;

11/22/2019

Featured CME Course

Targeted Therapies for the Management of Chronic Lymphocytic Leukemia: Evaluating the Evidence to Optimize Patient Care and Outcomes

Upcoming Events

February 2 ⁠–⁠ February 5

February 7 ⁠–⁠ February 9

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

March 22 ⁠–⁠ March 23

March 27 ⁠–⁠ March 30

March 31 ⁠–⁠ April 2

April 21 ⁠–⁠ April 24

April 30 ⁠–⁠ May 4

May 1 ⁠–⁠ May 3

See Full Calendar

Craig Nelson, MD

Featured CME Course

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products